Angela Fitch, MD, co-founder and chief medical officer of Knownwell and past president of the Obesity Medicine Association, ...

A Japanese case report of co-localized psoriasis and vitiligo reveals that IL-23 blockade cleared psoriasis but not vitiligo, ...

While TB and meningitis are rare among patients receiving systemic psoriasis therapies, IL-17 inhibitors increase the risk for candidiasis.

Psoriasis is often called a skin condition, which is a bit like calling a house fire a smoke problem. It is an immune disease ...

While dermatologists prescribe coal tar shampoos for specific scalp conditions, it’s important to understand when and how ...

Dr. Kristen Lo Sicco and Dr. Jerry Shapiro, hair loss specialists and board-certified dermatologists at NYU Langone, shared ...

Arcutis Biotherapeutics, Inc. announced data presented across its ZORYVE® (roflumilast) portfolio as well as real-world research on the long-term use of topical corticosteroids at the 35thEuropean ...

If envudeucitinib gains approval, it will join an increasingly competitive market flanked by drugs like J&J’s Icotyde, Amgen’s Otezla and BMS’ Sotyktu.

Multi-country discrete-choice experiment presented at the Fall Clinical Dermatology Conference demonstrates that skin ...

Johnson & Johnson (NYSE: JNJ) today announced new two-year results from the Phase 3 ICONIC-LEAD a  study evaluating ICOTYDE ®  (icotrokinra), the first and only targeted oral peptide that precisely ...

Presentation of data from the INTEGUMENT-INFANT trial of investigational ZORYVE cream 0.05% in infants ages 3 to <24 months, where treatment options remain limitedNew analyses from the ARRECTOR and DE ...

A new NHANES-based study of 11,668 US adults finds that a higher red blood cell distribution width-to-albumin ratio is ...